Eastman Q2 adjusted EPS falls to $1.60 from $2.15 as sales decline 3%
Eastman Chemical reported second-quarter 2025 sales of $2.29 billion, down 3% from a year earlier, and adjusted earnings per diluted share of $1.60 versus $2.15. Lower volumes in Fibers, Chemical Intermediates and Advanced Materials drove the decline, and the company projected third-quarter adjusted EPS of about $1.25 and full-year operating cash flow of about $1 billion, with inventory reduction expected to weigh on earnings in the second half.
Key points
- Q2 2025 sales $2,287 million vs. $2,363 million in Q2 2024; GAAP diluted EPS $1.20 vs. $1.94
- Adjusted EBIT $275 million vs. $353 million; operating cash flow $233 million vs. $367 million
- Third-quarter 2025 adjusted EPS projected at about $1.25; full-year operating cash flow expected at about $1 billion
- Plans to cut inventory by more than $200 million, with a $75 million to $100 million earnings headwind in the back half of 2025
The filing
Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.